Did the COVID-19 pandemic propel usage of AI in pharmaceutical innovation? : new evidence from patenting data
Year of publication: |
2024
|
---|---|
Authors: | Rathi, Sawan ; Majumdar, Adrija ; Chatterjee, Chirantan |
Published in: |
Technological forecasting and social change : an international journal. - Amsterdam [u.a.] : Elsevier Science, ISSN 0040-1625, ZDB-ID 2015184-6. - Vol. 198.2024, Art.-No. 122940, p. 1-15
|
Subject: | AI | Innovation management | Pandemic | Patents | Pharmaceutical industry | Patent | Pharmaindustrie | Coronavirus | Innovation | Epidemie | Epidemic | Arzneimittel | Pharmaceuticals | Innovationsmanagement | Wirkungsanalyse | Impact assessment | Pharmakologie | Pharmacology | Patentrecht | Patent law | Welt | World |
-
National and global vaccine procurement in a pandemic situation: rational patent replacement option
Welfens, Paul J. J., (2021)
-
Covid-19 vaccines, innovation, and intellectual property rights
Cozzi, Guido, (2022)
-
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Ravi, Srividya, (2022)
- More ...
-
Rathi, Sawan, (2022)
-
Do Stronger IPR Incentivize Female Participation in Innovation? Evidence from Chinese AI Patents
Agrawal, Shubhangi, (2024)
-
Rathi, Sawan, (2021)
- More ...